• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病与眼睑恶性皮肤病变的关系。

Relationship between actinic keratosis and malignant skin lesions on the eyelid.

机构信息

Post-Doctorate Program in Ophthalmology, Department of Ophthalmology, Universidade de São Paulo, São Paulo, SP, Brazil.

Department of Ophthalmology, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Arq Bras Oftalmol. 2023 Jan-Feb;86(1):1-6. doi: 10.5935/0004-2749.20230002.

DOI:10.5935/0004-2749.20230002
PMID:35170648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11826671/
Abstract

PURPOSE

To evaluate the variables possibly related to actinic keratosis and malignant skin lesions on the eyelid.

METHODS

A prospective study of patients with suspected eyelid malignancy was conducted. The participants underwent a 2-mm punch biopsy at two opposite sites of the lesion for diagnosis, and the results were compared with those of the histopathological study of the surgical excised specimen. The patients with an actinic keratosis component were divided into two groups (actinic keratosis-associated malignancy and actinic keratosis alone), which were compared for the following variables: age, disease duration, largest diameter, tumor area, Fitzpatrick classification, sex, tumor site and margin involvement. A cluster analysis was also performed.

RESULTS

We analyzed 174 lesions, of which 50 had an actinic keratosis component. Actinic keratosis was associated with squamous cell carcinoma in 22% of the cases and to basal cell carcinoma in 38%, which shows that both neoplasms may have contiguous actinic keratosis. Statistical analysis revealed no significant difference among the variables. In a cluster analysis, four groups were identified with malignant lesions in the medial canthus with the largest mean diameter and area. All margin involvements on the lower eyelid were related to malignancy, which means that all cases with margin involvement had an almost 100% risk of malignancy.

CONCLUSIONS

Larger actinic keratosis lesions in the medial canthus and lesions with margin involvement on the lower eyelid have a greater probability of malignant association.

摘要

目的

评估与光化性角化病和眼睑恶性皮肤病变相关的变量。

方法

对疑似眼睑恶性肿瘤的患者进行了一项前瞻性研究。参与者在病变的两个相对部位进行 2 毫米的环钻活检以进行诊断,并将结果与手术切除标本的组织病理学研究结果进行比较。具有光化性角化病成分的患者被分为两组(光化性角化病相关恶性肿瘤和单纯光化性角化病),比较以下变量:年龄、病程、最大直径、肿瘤面积、Fitzpatrick 分类、性别、肿瘤部位和边缘受累。还进行了聚类分析。

结果

我们分析了 174 个病变,其中 50 个有光化性角化病成分。光化性角化病与鳞状细胞癌相关的占 22%,与基底细胞癌相关的占 38%,这表明这两种肿瘤可能有连续的光化性角化病。统计学分析显示,各变量之间无显著性差异。在聚类分析中,发现 4 个组存在内眦恶性病变,其最大平均直径和面积较大。所有下眼睑的边缘受累均与恶性肿瘤有关,这意味着所有边缘受累的病例恶性肿瘤的风险几乎为 100%。

结论

内眦较大的光化性角化病病变和下眼睑边缘受累的病变与恶性病变的相关性更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ef/11826671/1f43ab30c148/abo-86-01-0001-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ef/11826671/d187d82a0c84/abo-86-01-0001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ef/11826671/1f43ab30c148/abo-86-01-0001-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ef/11826671/d187d82a0c84/abo-86-01-0001-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5ef/11826671/1f43ab30c148/abo-86-01-0001-g02.jpg

相似文献

1
Relationship between actinic keratosis and malignant skin lesions on the eyelid.光化性角化病与眼睑恶性皮肤病变的关系。
Arq Bras Oftalmol. 2023 Jan-Feb;86(1):1-6. doi: 10.5935/0004-2749.20230002.
2
Clinicopathological study of 21 cases of eyelid actinic keratosis.21例眼睑光化性角化病的临床病理研究
Int Ophthalmol. 2009 Oct;29(5):379-84. doi: 10.1007/s10792-008-9251-1. Epub 2008 Jul 17.
3
Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy.局部应用 5-氟尿嘧啶治疗眼周光化性角化病和低级别鳞状上皮内瘤变。
Ophthalmic Plast Reconstr Surg. 2012 May-Jun;28(3):181-3. doi: 10.1097/IOP.0b013e3182467c68.
4
Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects.对皮肤场癌化活性特征的贡献:形态计量学、染色质纹理、增殖及凋亡方面
An Bras Dermatol. 2019 Nov-Dec;94(6):698-703. doi: 10.1016/j.abd.2019.03.003. Epub 2019 Oct 25.
5
[Expression of cell proliferation and apoptosis biomarkers in skin spinocellular carcinoma and actinic keratosis].[皮肤棘细胞癌和光化性角化病中细胞增殖与凋亡生物标志物的表达]
An Bras Dermatol. 2009 Sep-Oct;84(5):469-75. doi: 10.1590/s0365-05962009000500004.
6
The value of the histopathologic examination in the diagnosis and management of the actinic keratosis.组织病理学检查在光化性角化病诊断和治疗中的价值。
Rom J Morphol Embryol. 2012;53(4):927-34.
7
The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.p53和COX-2在基底细胞癌、鳞状细胞癌及光化性角化病病例中的表达
Turk Patoloji Derg. 2012;28(2):119-27. doi: 10.5146/tjpath.2012.01110.
8
[Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma].[光老化皮肤、光化性角化病病灶及基底细胞癌中基质金属蛋白酶1、9表达特征的免疫组织化学研究]
Arkh Patol. 2016;78(6):17-22. doi: 10.17116/patol201678617-22.
9
Eyelid tumours and pseudotumours in Hong Kong: a ten-year experience.香港眼睑肿瘤和假性肿瘤:十年经验。
Hong Kong Med J. 2013 Apr;19(2):150-5.
10
Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study.临床危险因素分析:光化性角化病或原位皮肤鳞状细胞癌患者皮肤鳞状细胞癌回顾性双队列研究。
Acta Derm Venereol. 2024 Nov 27;104:adv40990. doi: 10.2340/actadv.v104.40990.

本文引用的文献

1
Actinic keratosis - review for clinical practice.光化性角化病——临床实践综述。
Int J Dermatol. 2019 Apr;58(4):400-407. doi: 10.1111/ijd.14147. Epub 2018 Aug 2.
2
Diagnosis of aggressive subtypes of eyelid basal cell carcinoma by 2-mm punch biopsy: prospective and comparative study.通过2毫米打孔活检诊断眼睑基底细胞癌侵袭性亚型:前瞻性比较研究
Rev Col Bras Cir. 2016 Jul-Aug;43(4):262-9. doi: 10.1590/0100-69912016004008.
3
Current perspective on actinic keratosis: a review.光化性角化病的现状:综述。
Br J Dermatol. 2017 Aug;177(2):350-358. doi: 10.1111/bjd.14852. Epub 2016 Aug 8.
4
Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.光化性角化病的管理:来自AKTeam™专家临床医生的实用报告及治疗算法
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1141-9. doi: 10.1111/jdv.12434. Epub 2014 Mar 11.
5
The natural history of actinic keratosis: a systematic review.光化性角化病自然病史的系统评价。
Br J Dermatol. 2013 Sep;169(3):502-18. doi: 10.1111/bjd.12420.
6
Current issues in the management of actinic keratosis.光化性角化病治疗的当前问题。
J Am Acad Dermatol. 2013 Jan;68(1 Suppl 1):S28-38. doi: 10.1016/j.jaad.2012.09.051.
7
Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer.光化性角化病的治疗是非黑素瘤皮肤癌预防策略的关键组成部分。
J Clin Aesthet Dermatol. 2010 Jun;3(6):39-44.
8
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.光化性角化病:退伍军人事务部外用维甲酸化学预防试验中的自然史及恶性转化风险
Cancer. 2009 Jun 1;115(11):2523-30. doi: 10.1002/cncr.24284.
9
Clinicopathological study of 21 cases of eyelid actinic keratosis.21例眼睑光化性角化病的临床病理研究
Int Ophthalmol. 2009 Oct;29(5):379-84. doi: 10.1007/s10792-008-9251-1. Epub 2008 Jul 17.
10
Guidelines for the management of actinic keratoses.光化性角化病管理指南。
Br J Dermatol. 2007 Feb;156(2):222-30. doi: 10.1111/j.1365-2133.2006.07692.x.